Selenium Nanocomposites in Diagnosis, Drug Delivery, and Treatment

Shurygina, I. A.; Шурыгин, М. Г.

doi:10.1002/9781119671732.ch2

Nanobiotechnology in Diagnosis, Drug Delivery, and Treatment 2020

DOI: 10.1002/9781119671732.ch2

|View full text |Cite

Selenium Nanocomposites in Diagnosis, Drug Delivery, and Treatment

I. A. Shurygina

М. Г. Шурыгин

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 98 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Biosynthesis of selenium nanoparticles by Aspergillus flavus and Candida albicans for antifungal applications

Bafghi

Darroudi

Zargar

et al. 2021

Micro & Nano Letters

View full text Add to dashboard Cite

Biosynthesis of nanoparticles can replace the available chemical and physical methods by offering new procedures as green syntheses that have proved to be simple, biocompatible, safe, and cost-effective. Recently, antifungal resistance has been reported against different species of Aspergillus and Candida opportunistic fungi. Selenium nanoparticles (Se-NPs) were biosynthesized using standard strains of A. flavus and C. albicans. The presence of NPs was confirmed by UV-Vis, FT-IR, FESEM, EDX, XRD, and Zeta potential. Common fungal strains were cultured in Sabouraud dextrose agar medium to perform the sensitivity test based on the minimum inhibitory concentration (MIC) method in duplicate. The utilization of Se-NPs at concentrations of 1, 0.5, and 0.25 μg/mL or in some strains even more minor than 0.125 μg/mL resulted in zero growth of fungal agents. However, antifungal drugs inhibited their growth at concentrations of 2, 4, 8, 16, and 64 μg/mL itraconazole (ITC). Also, MIC breakpoints for amphotericin B (AMB) and anidulafungin (AFG) were 2 μg/mL for defining resistance in some isolates. Based on the obtained results, biological NPs produced by Aspergillus and Candida at different concentrations exhibited favourable inhibitory effects on the growth of fungal strains.

show abstract

Biosynthesis of selenium nanoparticles by Aspergillus flavus and Candida albicans for antifungal applications

Bafghi

Darroudi

Zargar

et al. 2021

Micro & Nano Letters

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Selenium Nanocomposites in Diagnosis, Drug Delivery, and Treatment

Cited by 1 publication

References 98 publications

Biosynthesis of selenium nanoparticles by Aspergillus flavus and Candida albicans for antifungal applications

Biosynthesis of selenium nanoparticles by Aspergillus flavus and Candida albicans for antifungal applications

Contact Info

Product

Resources

About